GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹9,948 Cr | ₹9,985 Cr | ₹8,860 Cr | ₹8,943 Cr | ₹8,280 Cr |
What is the latest Total Expenditure of GLENMARK PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹9,948 Cr |
Mar2023 | ₹9,985 Cr |
Mar2022 | ₹8,860 Cr |
Mar2021 | ₹8,943 Cr |
Mar2020 | ₹8,280 Cr |
How is Total Expenditure of GLENMARK PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹9,948 Cr | -0.36 | |
Mar2023 | ₹9,985 Cr | 12.70 | |
Mar2022 | ₹8,860 Cr | -0.93 | |
Mar2021 | ₹8,943 Cr | 8.01 | |
Mar2020 | ₹8,280 Cr | - |
Compare Total Expenditure of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹60,819.7 Cr | 0.5% | 22.9% | 49.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 0.5% |
22.9% |
49.7% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses